Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Bergman

Showing results (21-30 of 125) with videos related to

Pageof 13
Sort By:
CNS & Neurological Disorders Drug Targets|May 30, 2015
Dopamine D₄ Receptor Antagonists for the Treatment of Cocaine Use DisordersJack Bergman, Curtis G Rheingold
Behavioural Pharmacology|September 23, 2003
Applications of behavioural pharmacology in drug discoveryDavid Sanger, Paul Willner, Jack Bergman
Behavioural Pharmacology|November 9, 2019
Behavioural aspects of neuroinflammationPaul Willner, Louk Vanderschuren, Jack Bergman
Behavioural Pharmacology|August 2, 2013
Current approaches to the laboratory assessment of abuse potentialJack Bergman, Paul Willner, Louk Vanderschuren
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2021
Enhancement of Opioid Antinociception by Nicotinic LigandsFernando B de Moura, Jack Bergman
Behavioural Pharmacology|September 11, 2009
Behavioural pharmacology of impulse controlPaul Willner, Jack Bergman, David Sanger
Behavioural Pharmacology|August 19, 2010
Non-traditional drug targets in behavioural pharmacologyPaul Willner, Jack Bergman, Louk Vanderschuren
Behavioural Pharmacology|August 3, 2012
Pharmacological approaches to feeding behaviour and eating disordersPaul Willner, Jack Bergman, Louk Vanderschuren
Behavioural Pharmacology|March 19, 2019
The behavioural pharmacology of stress-related disordersPaul Willner, Jack Bergman, Louk Vanderschuren
Behavioural Pharmacology|August 13, 2011
Stimulus properties of drugs and the behavioural pharmacology of pain: in memory of Francis ColpaertPaul Willner, Jack Bergman, Louk Vanderschuren
Pageof 13

Showing results (21-30 of 125) with videos related to

Sort By:
Pageof 13
CNS & Neurological Disorders Drug Targets|May 30, 2015
Dopamine D₄ Receptor Antagonists for the Treatment of Cocaine Use DisordersJack Bergman, Curtis G Rheingold
Behavioural Pharmacology|September 23, 2003
Applications of behavioural pharmacology in drug discoveryDavid Sanger, Paul Willner, Jack Bergman
Behavioural Pharmacology|November 9, 2019
Behavioural aspects of neuroinflammationPaul Willner, Louk Vanderschuren, Jack Bergman
Behavioural Pharmacology|August 2, 2013
Current approaches to the laboratory assessment of abuse potentialJack Bergman, Paul Willner, Louk Vanderschuren
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2021
Enhancement of Opioid Antinociception by Nicotinic LigandsFernando B de Moura, Jack Bergman
Behavioural Pharmacology|September 11, 2009
Behavioural pharmacology of impulse controlPaul Willner, Jack Bergman, David Sanger
Behavioural Pharmacology|August 19, 2010
Non-traditional drug targets in behavioural pharmacologyPaul Willner, Jack Bergman, Louk Vanderschuren
Behavioural Pharmacology|August 3, 2012
Pharmacological approaches to feeding behaviour and eating disordersPaul Willner, Jack Bergman, Louk Vanderschuren
Behavioural Pharmacology|March 19, 2019
The behavioural pharmacology of stress-related disordersPaul Willner, Jack Bergman, Louk Vanderschuren
Behavioural Pharmacology|August 13, 2011
Stimulus properties of drugs and the behavioural pharmacology of pain: in memory of Francis ColpaertPaul Willner, Jack Bergman, Louk Vanderschuren
Pageof 13